Cargando…

Quantification of GC-biased gene conversion in the human genome

Much evidence indicates that GC-biased gene conversion (gBGC) has a major impact on the evolution of mammalian genomes. However, a detailed quantification of the process is still lacking. The strength of gBGC can be measured from the analysis of derived allele frequency spectra (DAF), but this appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Glémin, Sylvain, Arndt, Peter F., Messer, Philipp W., Petrov, Dmitri, Galtier, Nicolas, Duret, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510005/
https://www.ncbi.nlm.nih.gov/pubmed/25995268
http://dx.doi.org/10.1101/gr.185488.114
_version_ 1782382108706078720
author Glémin, Sylvain
Arndt, Peter F.
Messer, Philipp W.
Petrov, Dmitri
Galtier, Nicolas
Duret, Laurent
author_facet Glémin, Sylvain
Arndt, Peter F.
Messer, Philipp W.
Petrov, Dmitri
Galtier, Nicolas
Duret, Laurent
author_sort Glémin, Sylvain
collection PubMed
description Much evidence indicates that GC-biased gene conversion (gBGC) has a major impact on the evolution of mammalian genomes. However, a detailed quantification of the process is still lacking. The strength of gBGC can be measured from the analysis of derived allele frequency spectra (DAF), but this approach is sensitive to a number of confounding factors. In particular, we show by simulations that the inference is pervasively affected by polymorphism polarization errors and by spatial heterogeneity in gBGC strength. We propose a new general method to quantify gBGC from DAF spectra, incorporating polarization errors, taking spatial heterogeneity into account, and jointly estimating mutation bias. Applying it to human polymorphism data from the 1000 Genomes Project, we show that the strength of gBGC does not differ between hypermutable CpG sites and non-CpG sites, suggesting that in humans gBGC is not caused by the base-excision repair machinery. Genome-wide, the intensity of gBGC is in the nearly neutral area. However, given that recombination occurs primarily within recombination hotspots, 1%–2% of the human genome is subject to strong gBGC. On average, gBGC is stronger in African than in non-African populations, reflecting differences in effective population sizes. However, due to more heterogeneous recombination landscapes, the fraction of the genome affected by strong gBGC is larger in non-African than in African populations. Given that the location of recombination hotspots evolves very rapidly, our analysis predicts that, in the long term, a large fraction of the genome is affected by short episodes of strong gBGC.
format Online
Article
Text
id pubmed-4510005
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Cold Spring Harbor Laboratory Press
record_format MEDLINE/PubMed
spelling pubmed-45100052016-01-31 Quantification of GC-biased gene conversion in the human genome Glémin, Sylvain Arndt, Peter F. Messer, Philipp W. Petrov, Dmitri Galtier, Nicolas Duret, Laurent Genome Res Method Much evidence indicates that GC-biased gene conversion (gBGC) has a major impact on the evolution of mammalian genomes. However, a detailed quantification of the process is still lacking. The strength of gBGC can be measured from the analysis of derived allele frequency spectra (DAF), but this approach is sensitive to a number of confounding factors. In particular, we show by simulations that the inference is pervasively affected by polymorphism polarization errors and by spatial heterogeneity in gBGC strength. We propose a new general method to quantify gBGC from DAF spectra, incorporating polarization errors, taking spatial heterogeneity into account, and jointly estimating mutation bias. Applying it to human polymorphism data from the 1000 Genomes Project, we show that the strength of gBGC does not differ between hypermutable CpG sites and non-CpG sites, suggesting that in humans gBGC is not caused by the base-excision repair machinery. Genome-wide, the intensity of gBGC is in the nearly neutral area. However, given that recombination occurs primarily within recombination hotspots, 1%–2% of the human genome is subject to strong gBGC. On average, gBGC is stronger in African than in non-African populations, reflecting differences in effective population sizes. However, due to more heterogeneous recombination landscapes, the fraction of the genome affected by strong gBGC is larger in non-African than in African populations. Given that the location of recombination hotspots evolves very rapidly, our analysis predicts that, in the long term, a large fraction of the genome is affected by short episodes of strong gBGC. Cold Spring Harbor Laboratory Press 2015-08 /pmc/articles/PMC4510005/ /pubmed/25995268 http://dx.doi.org/10.1101/gr.185488.114 Text en © 2015 Glémin et al.; Published by Cold Spring Harbor Laboratory Press http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Method
Glémin, Sylvain
Arndt, Peter F.
Messer, Philipp W.
Petrov, Dmitri
Galtier, Nicolas
Duret, Laurent
Quantification of GC-biased gene conversion in the human genome
title Quantification of GC-biased gene conversion in the human genome
title_full Quantification of GC-biased gene conversion in the human genome
title_fullStr Quantification of GC-biased gene conversion in the human genome
title_full_unstemmed Quantification of GC-biased gene conversion in the human genome
title_short Quantification of GC-biased gene conversion in the human genome
title_sort quantification of gc-biased gene conversion in the human genome
topic Method
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510005/
https://www.ncbi.nlm.nih.gov/pubmed/25995268
http://dx.doi.org/10.1101/gr.185488.114
work_keys_str_mv AT gleminsylvain quantificationofgcbiasedgeneconversioninthehumangenome
AT arndtpeterf quantificationofgcbiasedgeneconversioninthehumangenome
AT messerphilippw quantificationofgcbiasedgeneconversioninthehumangenome
AT petrovdmitri quantificationofgcbiasedgeneconversioninthehumangenome
AT galtiernicolas quantificationofgcbiasedgeneconversioninthehumangenome
AT duretlaurent quantificationofgcbiasedgeneconversioninthehumangenome